Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401824
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-05-02
Brief Title:
Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases
Sponsor:
Maastricht University Medical Center
Organization:
Maastricht University Medical Center
Organization Data
Organization:
Maastricht University Medical Center
Class:
OTHER
Study ID:
CO-NL-979-6888
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Maastricht University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |